CRM vs PG: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and The Procter & Gamble Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-22.
Salesforce, Inc. Β· Technology
$236.42
+11.6% upside to fair value
Med Conviction Grade B High Quality
VS
The Procter & Gamble Company Β· Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction Grade B+ High Quality
QuantHub Verdict
PG has more upside to fair value (+14.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRM PG
Current Price $236.42 $147.04
Fair Value Estimate $263.88 $168.19
Upside to Fair Value +11.6% +14.4%
Market Cap $193.6B $349.5B
Forward P/E β€” β€”
EV / EBITDA 14.4x 17.6x
Price / Sales 4.4x 4.0x
Price / FCF 12.8x 22.4x
Revenue Growth YoY +10.8% +1.5%
Gross Margin 77.3% 50.2%
Operating Margin 21.4% 22.7%
Return on Equity 20.2% 29.8%
Dividend Yield 0.73% 2.92%
FCF Yield 7.82% 4.47%
Analyst Consensus Buy Buy
Investment Thesis
CRM β€” Salesforce, Inc.
Salesforce is the leading enterprise customer relationship management platform, spanning Sales, Service, Platform, Marketing, Commerce, Tableau, MuleSoft, and Slack under the Customer 360 umbrella, with 83,334 employees and a business that converts $53.65 of revenue per share into $18.48 of free cash flow per share. Business quality is high: TTM gross margin of 77.3%, TTM operating margin of 21.4…
PG β€” The Procter & Gamble Company
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
Metric CRM PG
Zone Low $197.91 $126.14
Zone High $224.30 $142.96
In Buy Zone? No No
← CRM Research    PG Research β†’    All Research